**📈 Bonus Shares on the Rise: Venus Pharmaceuticals in Focus**
Small-cap Venus Pharmaceuticals shares have been in focus recently, with the company’s stock closing 1.99% higher at ₹313.40 on Tuesday. Shareholders of Venus Pharmaceuticals will receive 3 shares for every 1 share held as a bonus.
The company has announced a record date for issuing bonus shares at a 3:1 ratio on April 20, 2024. Venus Pharmaceuticals Limited is a well-known public limited company with manufacturing facilities worldwide.
After the announcement of the record date for the 3:1 bonus shares by the board members, the pharmaceutical company’s shares surged by 2% on Monday, reaching an intraday high of ₹313.40.
**🚀 Strong Growth Potential**
Experts predict strong growth potential in this stock, which is currently trading at ₹313. The stock hit a 52-week high of ₹388.00 on March 7, 2024, while the 52-week low was ₹50.34.
There is a possibility of a slight further decline in the stock price, making it a good buy in the range of ₹215-240. The target for investment is between ₹350 to ₹500, with a stop loss of ₹200.
Keep an eye on Venus Pharmaceuticals as it continues to make waves in the market with its bonus shares and promising growth prospects. 🌟📊🔥**
Disclaimer: This is News Coverage with Opinions of Experts and Should Not Be Taken as Direct Market Buying Tip. Market is always subject to risk. We recommend taking our content as research before investing.
